A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Clinical trial NCT05589844 · WITHDRAWN
Trial details
- NCT number
- NCT05589844
- Sponsor
- Roswell Park Cancer Institute
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2024-11-16
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.